Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2014; 10(04): 341-356DOI: 10.1055/s-0034-1390808 Pädiatrische Intensivmedizin © Georg Thieme Verlag KG Stuttgart · New York Zerebrale Anfälle und Epilepsien im Kindesalter Thomas Bast Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Fisher RS, Acevedo C, Arzimanoglou A et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475-482 2 Berg AT, Berkovic SF, Brodie MJ et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685 3 Berg A, Jallon PZ, Preux PM. The epidemiology of seizure disorders in infancy and childhood: definitions and classifications. Handb Clin Neurol 2013; 111: 391-398 4 Forsgren L, Beghi E, Oun A. The epidemiology of epilepsy in Europe – a systematic review. Eur J Neurol 2005; 12: 245-253 5 Nabbout R, Scheffer IE. Genetics of idiopathic epilepsies. Handb Clin Neurol 2013; 111: 567-578 6 Bast T. Therapie von Epilepsien im Kindes- und Jugendalter. Z Epileptol 2013; 26: 134-141 7 Bast T, Carmant L. Febrile and other occasional seizures. Handb Clin Neurol 2013; 111: 477-491 8 Annegers JF, Coan SP. The risks of epilepsy after traumatic brain injury. Seizure 2000; 9: 453-457 9 Annegers JF, Grabow JD, Groover RV et al. Seizures after head trauma: a population study. Neurology 1980; 30: 683-689 10 Young KD, Okada PJ, Sokolove PE et al. A randomized, double-blinded, placebo-controlled trial of Phenytoin for the prevention of early posttraumatic seizures in children with moderate to severe blunt head injury. Ann Emerg Med 2004; 43: 435-446 11 Jones KE, Puccio AM, Harshman KJ et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus 2008; 25: E3 12 Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med 2002; 22: 235-239 13 Finkelstein Y, Hutson JR, Freedman SB et al. Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends. Clin Toxicol (Phila) 2013; 51: 761-766 14 Christ W, Mayer H, Wiemer-Kruel A. Methylphenidattherapie bei epilepsiekranken Kindern Ergebnisse einer doppelblinden Anwendungsbeobachtung. Monatsschr Kinderheilkd 2013; 161: 720-726 15 Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 2008; 28: 379-388 16 DeLorenzo RJ, Towne AR, Pellock JM et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46: 1029-1035 17 Bast T, Ludwig HC, Mücke KH et al. Notfälle bei behinderten Kindern. Notfallmedizin up2date 2009; 4: 157-178 18 National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical guidelines, CG137. – Issued: January 2012. Im Internet: http://guidance.nice.org.uk/cg137 19 Chin RF, Neville PG, Peckham C et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006; 368: 222-229 20 Eriksson K, Metsäranta P, Huhtala H et al. Treatment delay and the risk of prolonged status epilepticus. Neurology 2005; 65: 1316-1318 21 Alldredge BK, Gelb AM, Isaacs SM et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-637 22 Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006; 5: 246-256 23 Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999; 353: 623-626 24 McIntyre J, Robertson S, Norris E et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005; 366: 205-210 25 Chin RF, Neville BG, Peckham C et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008; 7: 696-703 26 Meierkord H, Boon P, Engelsen G et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17: 348-355 27 Nabbout R. FIRES and IHHE: Delineation of the syndromes. Epilepsia 2013; 54 (Suppl. 06) 54-56 28 Al-Aqeel S, Al-Sabhan J. Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev 2011; 19 29 Holtkamp M, Othman J, Buchheim K et al. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology 2006; 66: 1727-1729 30 Berg AT, Levy SR, Testa FM et al. Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol 2009; 65: 510-519 31 Steinhoff B, Bast T. Vademecum Antiepilepticum 2013/2014. Pharmakotherapie der Epilepsien. Deutsche Gesellschaft für Epileptologie e.V.; 2013 [zu beziehen über: Desitin Arzneimittel GmbH, Hamburg] 32 Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs) – part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet 2013; 52: 927-966 33 Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs) – Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders. Clin Pharmacokinet 2013; 52: 1045-1061 34 Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012; 25: 173-178 35 Leiendecker B, Klepper J. Medikamente und Supplemente bei ketogener Diät im Kindesalter. Neuropäd Klin Prax 2005; 4: 98-113 Im Internet: http://www.neuropaediatrie-online.com
